CIK 0001620463 · Non-accelerated filer<br>Smaller reporting company
LeonaBio, Inc.
Sign in to watch- Ticker
- LONA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 453368487
- Phone
- (425) 620-8501
- Business address
- 18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA, 98011
- Former names
- Athira Pharma, Inc., M3 Biotechnology, Inc.
- Open-market buys, last 90 days
- $9,919,161,281
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,919,161,281. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 85 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-04 | MOEBIUS HANS Chief Medical Officer | Grant or award | +10,000 | 91,482 | ||
| 2024-01-04 | Litton Mark James Chief Executive Officer | Grant or award | +20,000 | 149,217 | ||
| 2023-11-20 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +3,397 | $1.34 | $5K | 72,668 |
| 2023-05-18 | Worthington Mark GENERAL COUNSEL | Grant or award | +7,767 | $2.41 | $19K | 26,864 |
| 2023-05-18 | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | Grant or award | +809 | $2.41 | $2K | 69,271 |
| 2023-01-05 | Gengos Andrew See Below | Sale | −1,208 | $2.91 | $4K | 83,804 |
| 2023-01-04 | Gengos Andrew See Below | Grant or award | +5,000 | 85,012 |
Page 10 of 10 · 187 trades